CN111785333A - 基于生物学网络数据的药物作用靶点筛选方法、装置、电子设备及存储介质 - Google Patents
基于生物学网络数据的药物作用靶点筛选方法、装置、电子设备及存储介质 Download PDFInfo
- Publication number
- CN111785333A CN111785333A CN202010429918.3A CN202010429918A CN111785333A CN 111785333 A CN111785333 A CN 111785333A CN 202010429918 A CN202010429918 A CN 202010429918A CN 111785333 A CN111785333 A CN 111785333A
- Authority
- CN
- China
- Prior art keywords
- network data
- biological
- biological network
- database
- node
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 122
- 229940079593 drug Drugs 0.000 title claims abstract description 102
- 230000009471 action Effects 0.000 title claims abstract description 59
- 238000000034 method Methods 0.000 title claims abstract description 50
- 238000012216 screening Methods 0.000 title claims abstract description 37
- 201000010099 disease Diseases 0.000 claims abstract description 103
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 103
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 60
- 239000002131 composite material Substances 0.000 claims abstract description 35
- 208000024891 symptom Diseases 0.000 claims abstract description 30
- 238000004590 computer program Methods 0.000 claims description 15
- 238000012545 processing Methods 0.000 claims description 14
- 230000037361 pathway Effects 0.000 claims description 10
- 238000013507 mapping Methods 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 230000009466 transformation Effects 0.000 claims description 6
- 239000003596 drug target Substances 0.000 claims description 5
- 238000000729 Fisher's exact test Methods 0.000 claims description 3
- 230000010415 tropism Effects 0.000 claims 1
- 230000008569 process Effects 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 10
- 206010012601 diabetes mellitus Diseases 0.000 description 10
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 8
- 229940117916 cinnamic aldehyde Drugs 0.000 description 8
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 8
- 230000014509 gene expression Effects 0.000 description 6
- 239000002184 metal Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 238000010230 functional analysis Methods 0.000 description 3
- 208000030159 metabolic disease Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 102100036009 5'-AMP-activated protein kinase catalytic subunit alpha-2 Human genes 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 101150102539 E2F1 gene Proteins 0.000 description 2
- 101001077604 Homo sapiens Insulin receptor substrate 1 Proteins 0.000 description 2
- 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 2
- 101000798015 Homo sapiens RAC-beta serine/threonine-protein kinase Proteins 0.000 description 2
- 102100025087 Insulin receptor substrate 1 Human genes 0.000 description 2
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 2
- 102100032315 RAC-beta serine/threonine-protein kinase Human genes 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 102100022528 5'-AMP-activated protein kinase catalytic subunit alpha-1 Human genes 0.000 description 1
- 102100038074 5'-AMP-activated protein kinase subunit beta-1 Human genes 0.000 description 1
- 102100038049 5'-AMP-activated protein kinase subunit beta-2 Human genes 0.000 description 1
- 102100024627 5'-AMP-activated protein kinase subunit gamma-1 Human genes 0.000 description 1
- 102100024626 5'-AMP-activated protein kinase subunit gamma-2 Human genes 0.000 description 1
- 102100024628 5'-AMP-activated protein kinase subunit gamma-3 Human genes 0.000 description 1
- 102100028661 Amine oxidase [flavin-containing] A Human genes 0.000 description 1
- 102100028116 Amine oxidase [flavin-containing] B Human genes 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 102100032610 Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Human genes 0.000 description 1
- 101000783681 Homo sapiens 5'-AMP-activated protein kinase catalytic subunit alpha-2 Proteins 0.000 description 1
- 101000742701 Homo sapiens 5'-AMP-activated protein kinase subunit beta-1 Proteins 0.000 description 1
- 101000742799 Homo sapiens 5'-AMP-activated protein kinase subunit beta-2 Proteins 0.000 description 1
- 101000760992 Homo sapiens 5'-AMP-activated protein kinase subunit gamma-1 Proteins 0.000 description 1
- 101000760987 Homo sapiens 5'-AMP-activated protein kinase subunit gamma-2 Proteins 0.000 description 1
- 101000760977 Homo sapiens 5'-AMP-activated protein kinase subunit gamma-3 Proteins 0.000 description 1
- 101000694718 Homo sapiens Amine oxidase [flavin-containing] A Proteins 0.000 description 1
- 101000768078 Homo sapiens Amine oxidase [flavin-containing] B Proteins 0.000 description 1
- 101001014590 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas Proteins 0.000 description 1
- 101001014594 Homo sapiens Guanine nucleotide-binding protein G(s) subunit alpha isoforms short Proteins 0.000 description 1
- 101000852815 Homo sapiens Insulin receptor Proteins 0.000 description 1
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 1
- 101001014610 Homo sapiens Neuroendocrine secretory protein 55 Proteins 0.000 description 1
- 101000797903 Homo sapiens Protein ALEX Proteins 0.000 description 1
- 101000848721 Homo sapiens Rap guanine nucleotide exchange factor 4 Proteins 0.000 description 1
- 101001098812 Homo sapiens cGMP-inhibited 3',5'-cyclic phosphodiesterase B Proteins 0.000 description 1
- 101150034559 IGF1R gene Proteins 0.000 description 1
- 101150030450 IRS1 gene Proteins 0.000 description 1
- 102100036721 Insulin receptor Human genes 0.000 description 1
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 description 1
- 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 description 1
- 102100028452 Nitric oxide synthase, endothelial Human genes 0.000 description 1
- 101710090055 Nitric oxide synthase, endothelial Proteins 0.000 description 1
- 101150060880 PRKAA1 gene Proteins 0.000 description 1
- 101150004011 PRKAA2 gene Proteins 0.000 description 1
- 102100034591 Rap guanine nucleotide exchange factor 4 Human genes 0.000 description 1
- 101100397598 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) JNM1 gene Proteins 0.000 description 1
- 102100036782 Serine/threonine-protein phosphatase 2A activator Human genes 0.000 description 1
- 101710196539 Serine/threonine-protein phosphatase 2A activator Proteins 0.000 description 1
- 101100397001 Xenopus laevis ins-a gene Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 102100037094 cGMP-inhibited 3',5'-cyclic phosphodiesterase B Human genes 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 101150032953 ins1 gene Proteins 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003990 molecular pathway Effects 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 229920000327 poly(triphenylamine) polymer Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000007671 third-generation sequencing Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/50—Molecular design, e.g. of drugs
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
Landscapes
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Computing Systems (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims (9)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2020102022903 | 2020-03-20 | ||
CN202010202290 | 2020-03-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111785333A true CN111785333A (zh) | 2020-10-16 |
CN111785333B CN111785333B (zh) | 2022-02-25 |
Family
ID=72754255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010429918.3A Active CN111785333B (zh) | 2020-03-20 | 2020-05-20 | 基于生物学网络数据的药物作用靶点筛选方法、装置、电子设备及存储介质 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111785333B (zh) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104978474A (zh) * | 2014-04-11 | 2015-10-14 | 中国中医科学院中医临床基础医学研究所 | 一种基于分子网络的药效评价方法及*** |
CN105354779A (zh) * | 2015-10-31 | 2016-02-24 | 大连医科大学 | 一种用于复杂大脑疾病靶向组合治疗分析的***及方法 |
US20160213328A1 (en) * | 2013-09-13 | 2016-07-28 | Julia Morris HOENG | Systems and methods for evaluating perturbation of xenobiotic metabolism |
CN106055921A (zh) * | 2016-05-27 | 2016-10-26 | 华中农业大学 | 基于基因表达和药物靶标的药物活性预测与筛选方法 |
CN107292126A (zh) * | 2017-05-04 | 2017-10-24 | 浙江大学 | 一种中药对复杂性疾病所致“失和”网络整合调节作用的定量评价方法 |
CN108121896A (zh) * | 2017-12-19 | 2018-06-05 | 深圳先进技术研究院 | 一种基于miRNA的疾病间关系分析方法和装置 |
CN109493925A (zh) * | 2018-11-20 | 2019-03-19 | 北京晶派科技有限公司 | 一种确定药物和药物靶点关联关系的方法 |
CN110618987A (zh) * | 2019-09-18 | 2019-12-27 | 宁夏大学 | 基于肺癌医学大数据的治疗通路关键结点信息处理方法 |
US20200090789A1 (en) * | 2018-03-27 | 2020-03-19 | Innoplexus Ag | System and method for identifying potential targets for pharmaceutical compound |
-
2020
- 2020-05-20 CN CN202010429918.3A patent/CN111785333B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20160213328A1 (en) * | 2013-09-13 | 2016-07-28 | Julia Morris HOENG | Systems and methods for evaluating perturbation of xenobiotic metabolism |
CN104978474A (zh) * | 2014-04-11 | 2015-10-14 | 中国中医科学院中医临床基础医学研究所 | 一种基于分子网络的药效评价方法及*** |
CN105354779A (zh) * | 2015-10-31 | 2016-02-24 | 大连医科大学 | 一种用于复杂大脑疾病靶向组合治疗分析的***及方法 |
CN106055921A (zh) * | 2016-05-27 | 2016-10-26 | 华中农业大学 | 基于基因表达和药物靶标的药物活性预测与筛选方法 |
CN107292126A (zh) * | 2017-05-04 | 2017-10-24 | 浙江大学 | 一种中药对复杂性疾病所致“失和”网络整合调节作用的定量评价方法 |
CN108121896A (zh) * | 2017-12-19 | 2018-06-05 | 深圳先进技术研究院 | 一种基于miRNA的疾病间关系分析方法和装置 |
US20200090789A1 (en) * | 2018-03-27 | 2020-03-19 | Innoplexus Ag | System and method for identifying potential targets for pharmaceutical compound |
CN109493925A (zh) * | 2018-11-20 | 2019-03-19 | 北京晶派科技有限公司 | 一种确定药物和药物靶点关联关系的方法 |
CN110618987A (zh) * | 2019-09-18 | 2019-12-27 | 宁夏大学 | 基于肺癌医学大数据的治疗通路关键结点信息处理方法 |
Non-Patent Citations (2)
Title |
---|
QIANG ZENG ET AL: "A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer’s disease", 《BIOMEDICINE & PHARMACOTHERAPY》 * |
陈寅萤等: "网络分析方法在疾病和药物研究中的应用", 《中国中药杂志》 * |
Also Published As
Publication number | Publication date |
---|---|
CN111785333B (zh) | 2022-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Burger | Gentle introduction to the statistical foundations of false discovery rate in quantitative proteomics | |
Ji et al. | Machine learning for perturbational single-cell omics | |
Chowdhury et al. | (Differential) co-expression analysis of gene expression: a survey of best practices | |
Schbath et al. | Mapping reads on a genomic sequence: an algorithmic overview and a practical comparative analysis | |
Yeang et al. | Validation and refinement of gene-regulatory pathways on a network of physical interactions | |
Grafahrend-Belau et al. | Modularization of biochemical networks based on classification of Petri net t-invariants | |
Liu et al. | A novel data structure to support ultra-fast taxonomic classification of metagenomic sequences with k-mer signatures | |
Dong et al. | Reverse enGENEering of regulatory networks from big data: a roadmap for biologists | |
Meher et al. | Prediction of donor splice sites using random forest with a new sequence encoding approach | |
Yu et al. | Predicting protein complex in protein interaction network-a supervised learning based method | |
Li et al. | BioSeq-Diabolo: Biological sequence similarity analysis using Diabolo | |
Zhang et al. | How to balance the bioinformatics data: pseudo-negative sampling | |
Wu et al. | idenPC-MIIP: identify protein complexes from weighted PPI networks using mutual important interacting partner relation | |
Eldjárn Hjörleifsson et al. | Accurate quantification of single-cell and single-nucleus RNA-seq transcripts using distinguishing flanking k-mers | |
US10607720B2 (en) | Associating gene expression data with a disease name | |
Yi et al. | Information-incorporated Gaussian graphical model for gene expression data | |
Chen et al. | Forest Fire Clustering for single-cell sequencing combines iterative label propagation with parallelized Monte Carlo simulations | |
Li et al. | An effective tri-clustering algorithm combining expression data with gene regulation information | |
Wang et al. | An ensemble learning framework for detecting protein complexes from PPI networks | |
Acharya et al. | Multi-factored gene-gene proximity measures exploiting biological knowledge extracted from gene ontology: application in gene clustering | |
Carlin et al. | Prophetic Granger Causality to infer gene regulatory networks | |
CN111785333B (zh) | 基于生物学网络数据的药物作用靶点筛选方法、装置、电子设备及存储介质 | |
CN115798601A (zh) | 肿瘤特征基因识别方法、装置、设备及存储介质 | |
Liu et al. | Overlapping functional modules detection in PPI network with pair‐wise constrained non‐negative matrix tri‐factorisation | |
Gómez-Vela et al. | Structure optimization for large gene networks based on greedy strategy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220127 Address after: 518000 No. 12, Langshan Road, Xili street, Nanshan District, Shenzhen, Guangdong Applicant after: Shenzhen Hospital, Fuwai Hospital, Chinese Academy of Medical Sciences Address before: 518000 Shenzhen Hospital, Fuwai Hospital, Chinese Academy of Medical Sciences, No. 12, Langshan Road, Nanshan District, Shenzhen, Guangdong Applicant before: Zhao Honglei |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231206 Address after: No.1017 Dongmen North Road, Luohu District, Shenzhen, Guangdong 518000 Patentee after: SHENZHEN PEOPLE'S Hospital Address before: 518000 No. 12, Langshan Road, Xili street, Nanshan District, Shenzhen, Guangdong Patentee before: Shenzhen Hospital, Fuwai Hospital, Chinese Academy of Medical Sciences |